title: [Renal function after administration of angiotensin-converting enzyme inhibitors].
abstract: Angiotensin converting enzyme (ACE) inhibitors are widely used today for the management of hypertension and congestive heart failure. These agents inhibit angiotensin II synthesis. In some particular circumstances they may be responsible for deterioration of renal function, e.g. in hypertensive patients with bilateral renal artery stenosis or with stenosis of the artery supplying a single kidney, or in patients with severe congestive heart failure or marked nephroangiosclerosis. In these patients renal perfusion pressure may become too low to maintain adequate glomerular filtration as there remains no angiotensin II to increase the tone of the efferent arteriole. In high risk patients it is therefore recommended that serum creatinine be checked after initiating therapy with an ACE inhibitor.
authors: Division d'hypertension, Centre hospitalier universitaire vaudois, Lausanne.
authors: B
authors: B
authors: Waeber
authors: M
authors: M
authors: Burnier
authors: J
authors: J
authors: Nussberger
authors: H R
authors: HR
authors: Brunner
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D006978:Hypertension, Renovascular / Q000188:drug therapy / Q000503:physiopathology; D007668:Kidney / Q000187:drug effects*; D007676:Kidney Failure, Chronic / Q000139:chemically induced*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D003404:Creatinine
vernacular_title: La fonction rénale sous inhibition de l'enzyme de conversion de l'angiotensine.